TPP-resveratrol

TPP-resveratrol is a conjugate of Resveratrol (HY-16561) and triphenylphosphine (TPP) with anticancer activity. TPP-resveratrol increases the potency of Resveratrol through mitochondrial-targeted delivery and induces mitochondria-mediated apoptosis[1].

Product Specifications

UNSPSC

12352005

Target

Apoptosis

Type

Reference compound

Related Pathways

Apoptosis

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/tpp-resveratrol.html

Purity

99.76

Solubility

DMSO : 116.67 mg/mL (ultrasonic)

Smiles

O=C(CCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)OC4=CC(O)=CC(/C=C/C5=CC=C(C=C5)O)=C4.[Br-]

Molecular Formula

C36H32BrO4P

Molecular Weight

639.51

References & Citations

[1]Jiang L, et al. The anti-cancer effects of mitochondrial-targeted triphenylphosphonium–resveratrol conjugate on breast cancer cells[J]. Pharmaceuticals, 2022, 15 (10) : 1271.